Find Academic Supervisors

Emmanuel Stamatakis is a Professor of Physical Activity, Lifestyle, and Population Health at the University of Sydney's School of Health Sciences (Faculty of Medicine and Health). He holds NHMRC Leadership Fellowships (2021-2025 and 2026-2030) and leads the Charles Perkins Centre's Physical Activity & Exercise Theme. His research focuses on lifestyle behaviors' impacts on cardiometabolic conditions, cancer, and cardiovascular health, using large-scale cohort studies and wearable device data. Key roles include directing the Mackenzie Wearables Research Hub and co-chairing WHO's Physical Activity Guidelines Development Group. Education: PhD from University of Bristol (2003), post-doctoral training at University College London. He leads the ProPASS consortium, involving 45 cohorts with wearable data. Over 460 peer-reviewed publications, including Clarivate's Highly Cited list since 2019. Research interests integrate physical activity, sedentary behavior, and sleep analytics with clinical outcomes. Current projects explore wearables-based measurement innovations, SPAN (sleep-physical activity-nutrition) synergies, and intervention designs for GLP-1 receptor agonist users. Recent articles emphasize VILPA (vigorous intermittent lifestyle physical activity) benefits, sleep-cardiovascular links, and multimodal lifestyle optimization. Awards include Australia's Top Researcher in Sports Medicine and multiple NHMRC grants. Supervises PhD projects on physical activity measurement and intervention design. Active in 50+ peer-reviewed journals and national/international funding bodies.

• Physical Activity Epidemiology
• Public Health
• Cardiometabolic Health
• +4 more

Professor Thomas Astell-Burt is a Professor of Cities and Planetary Health at the University of Sydney's School of Architecture, Design and Planning. His work focuses on the intersection of urban environments, green spaces, and public health. He is a member of the Sydney Environment Institute and the Charles Perkins Centre. His research examines how urban planning and green infrastructure can mitigate health inequities, combat climate change, and improve mental/cardiometabolic health. Key areas include nature prescriptions, heat-related mortality, and the role of green spaces in reducing loneliness. Recent grants include projects on aged care workforce sustainability, nature-based strategies for loneliness reduction, and the PANDA Trial for cardiometabolic disease prevention. Over 180+ publications span peer-reviewed journals like Scientific Reports , Climate , and PloS One , with a focus on global health trends and urban environmental policies. His work bridges epidemiology, urban design, and interdisciplinary collaboration to inform evidence-based health policies. Key affiliations include leadership roles in global health initiatives and collaborations with institutions like the University of Glasgow. His research has been cited in policy frameworks addressing urban sustainability and planetary health.

• Planetary Health
• Urban Planning
• Public Health
• +5 more

Hsei Di Law is a Research Fellow at the National Centre for Epidemiology and Population Health (NCEPH), part of the Australian National University (ANU). She is concurrently pursuing an MSc in Computational Data Analytics at the Georgia Institute of Technology . Her work focuses on data linkage, machine learning, and epidemiological study design using whole-of-population linked datasets. Research Affiliations National Centre for Epidemiology and Population Health (ANU) Centre of Epidemiology for Policy and Practice Linked Data for Better Health group Health Experience and Health Services Research collaborator Research Interests : Hsei Di Law's work centers on large-scale linked administrative datasets and longitudinal data analysis , with applications in environmental contamination (PFAS, asbestos), healthcare economics (out-of-pocket costs), and epidemiology of diseases. She specializes in integrating machine learning techniques with epidemiological study design to address policy-relevant questions. Publication Trends : Her recent publications (2025–2023) analyze healthcare affordability in Australia, PFAS environmental health impacts , and data linkage methodologies . Over 2022–2015, she studied cardiovascular risk under-treatment , COVID-19 healthcare outcomes , and immune system disorders using mouse models. Projects Led : She is involved in multiple projects, including the ACT Asbestos Health Study II , PFAS Health Study , and Whole-of-population linked data project . These projects examine the health effects of asbestos and PFAS contamination , healthcare utilization, and epidemiological modeling . Contact : Email: hsei-di.law@anu.edu.au Phone: +61 2 6125 0547 Location: Building 62A, Room 2.56, ANU

• Data Linkage
• Machine Learning
• Epidemiological Study Design
• +3 more

Suzanne Estaphan is a Senior Lecturer in Medical Science (Physiology and Clinical Pharmacology) at the Australian National University (ANU) School of Medicine and Psychology . She holds qualifications including a Doctorate of Physiology (2015) , MSc in Physiology (2012) , MBBCh (2005) , and Basic Certificate in Medical Education (2018) . Her academic roles span curriculum development, admissions, and assessment committees in the ANU Medical School. Senior Lecturer, ANU (2023–present) Academic Editor, PLOS ONE (2024–present) Review Editor, Frontiers in Physiology (2023–present) Dr. Estaphan's research bridges oxidative stress and inflammation in disease pathology with medical education innovation . Her work explores antioxidant interventions for organ damage and investigates AI/virtual reality applications in education. Recent projects include studying sleep dysfunction in eating disorders and diabetes medication effects on exercise capacity . Between 2023–2025, her 15 most recent publications span oxidative stress , medical education , and molecular pathophysiology . Themes include homeostasis , clinical reasoning , and metabolic disorders , with subfields like MMP-9 biology , pancreatic injury , and VR-based hypoxia training . Scientific accolades include the American Physiological Society Travel Award (2017) and recognition as Senior Fellow of the Higher Education Academy (2023) . She mentors medical students, contributes to national physiology curriculum consensus projects, and has secured approximately $200,000 in research funding .

• Medical Physiology
• Oxidative Stress and Inflammation
• Medical Education Research
• +2 more

Professor Ester Cerin is a leading academic at the Mary Mackillop Institute for Health Research, Australian Catholic University (ACU), where she leads the Behaviour, Environment and Cognition Research Program. She holds an adjunct professorship in Statistics at the Department of Community Medicine, UiT The Arctic University of Norway, and is an Honorary Professorial Fellow at both the Baker Heart & Diabetes Institute and the School of Public Health, University of Hong Kong. Her international career includes academic roles in Australia, the USA, and Hong Kong. Her research centers on the environmental and psychosocial determinants of lifestyle behaviors and health, with a focus on physical activity, cognitive health, and sustainable environments. She employs advanced statistical methods to study how urban design and neighborhood characteristics influence health across the lifespan. Her work bridges public health, urban planning, and behavioral science. The recent publications highlight a consistent focus on built environment impacts on physical activity and cognitive health across age groups and continents. Her studies frequently employ multi-country designs (e.g., IPEN, iMAP) and advanced methodologies including meta-analyses, cohort studies, and objective environmental assessments. Key themes include walkability, urban densification, aging, and mental health. Top 1% of scholars, University of Hong Kong, 2015 Clarivate Highly Cited Researcher, 2019 Professor Cerin has secured over $24 million in research funding from prestigious bodies including NHMRC, ARC, NIH, and World Cancer Research Fund. She has led 12 major grants as Lead Investigator and serves as Principal Investigator for the iMAP and EPOCH studies. She supervises HDR students and mentors early-career researchers. Her leadership extends to editorial roles as Deputy Editor-in-Chief of the International Journal of Behavioral Nutrition and Physical Activity and Associate Editor of Health & Place . She co-founded the International Cognitive Health and the Environment Network (ICHEN) to promote research and advocacy for environments that support cognitive health. Her work is embedded in large international collaborations, including multi-country cohort studies and systematic reviews under the IPEN and CEPA working groups.

• Environmental Determinants of Health
• Psychosocial Determinants of Health
• Physical Activity
• +12 more

Rachel Huxley is Deakin Distinguished Professor and Executive Dean of the Faculty of Health at Deakin University, a role she has held since October 2019. She leads the Faculty of Health and is based at the Melbourne Burwood Campus. She previously served as Associate Pro-Vice Chancellor (Research) at La Trobe University, Chair in Epidemiology at the University of Queensland, and Head of the School of Public Health at Curtin University. She holds honorary appointments at the George Institute for Global Health (UNSW) and the Nuffield Department of Population Health, University of Oxford. Education: Undergraduate studies at St John's College, Oxford Doctorate in Epidemiology and Public Health, Department of Public Health and Primary Care, Oxford University Post-doctoral training at Oxford University Professor Huxley's research centers on epidemiology and public health, with a focus on chronic disease risk factors, sex and ethnic disparities, and the health impacts of climate change and air pollution. Her work spans cardiovascular disease, obesity, diabetes, women's health, and environmental determinants of health. She has published over 200 research articles and maintains an h-index of 58 (Web of Science). The 15 most recent publications reflect a strong interdisciplinary focus on environmental health, mental health, cardiometabolic disease, and health policy. Key themes include air pollution and child obesity, climate change and asthma, green space and psychiatric disorders, and sex disparities in coronary heart disease care. Her research increasingly integrates planetary health, policy reform, and equity considerations. Scientific Awards and Fellowships: Inaugural Career Development Fellowship from the Heart Foundation and NSW Office for Science and Medical Research Career Development Award ($400K) from NSW and National Heart Foundation of Australia (2009–2010) Professor Huxley has secured over $2.5 million as Chief Investigator A and contributed to more than $5 million in co-investigator grants. Current and recent projects include NHMRC-funded studies on obesity, prediabetes, electronic cigarettes, women's health data, CT scanning risks, and coronary heart disease management. She supervises several doctoral students and is actively involved in national and international advisory boards, including the Telethon Kids Institute and the Australian Clinical Trials Alliance. She leads or contributes to major research initiatives such as the Centre of Research Excellence on Women and Non-communicable Disease (CRE WaND) and the Breathe Melbourne citizen science project. Her leadership extends to policy engagement, with research influencing public health strategies on air quality, climate change, and sex and gender equity in research.

• Epidemiology
• Public Health
• Cardiovascular Medicine
• +9 more

Associate Professor Nadine Andrew is an Associate Professor (Research) in the Department of Medicine at Monash University's School of Translational Medicine. She leads the National Centre for Healthy Ageing Data Platform and chairs the Monash HELIX data linkage committee. With expertise in data linkage and health services research, her work focuses on chronic diseases of aging, stroke, and dementia. She has secured over $12M in grants and leads projects like the NHMRC-funded PRECISE stroke study and a MRFF digital health initiative for aged care transfers. Her team includes experts in epidemiology, data science, and bioinformatics. Education: PhD in Epidemiology, Master’s in Public Health, clinical background in Physiotherapy. Research Interests: Data linkage methodologies, stroke epidemiology, chronic disease management, digital health solutions for aging populations. She pioneers national data platforms and co-designs patient-centered care systems. Grants & Projects: $2M MRFF grant for digital health in aged care, NHMRC PRECISE project, boosting dementia grant. Active in 20+ collaborative initiatives including national stroke data integration and vulnerable population cohort studies. Awards: 2024 Australian Epidemiological Association Award, 2021 American Heart Association Reviewer Award, NHMRC Early Career Fellowship (2014). Labs/Teams: Directs the National Centre for Healthy Ageing Data Platform and oversees multidisciplinary research teams advancing EHR data utilization.

• Data linkage
• Stroke
• Chronic Disease Prevention and Management
• +5 more

Dr Bastien Lechat is a Research Fellow at Flinders Health and Medical Research Institute (FHMRI): Sleep Health, within the College of Medicine and Public Health at Flinders University. He is also a Full Member of the College of Science and Engineering and the Medical Device Research Institute. As an NHMRC Emerging Leadership Fellow, he leads innovative research at the intersection of sleep medicine, artificial intelligence, and wearable technology. Education: PhD in Sleep Health, Adelaide Institute for Sleep Health, Flinders University (2018–2021) Bachelor of Engineering in Engineering Science/Acoustics, Université du Maine, France (2014–2017) Dr Lechat’s research focuses on understanding the physiological mechanisms and consequences of obstructive sleep apnea (OSA), particularly night-to-night variability and patient subtypes. He develops AI-driven tools for efficient and accurate diagnosis using wearables and signal processing. His work aims to create a scalable, low-cost model of care for sleep-disordered breathing, addressing global diagnostic gaps. His recent publications reveal a strong trend in digital health innovation, with a focus on machine learning for OSA detection, circadian rhythm modeling, cardiovascular risk prediction, and climate impacts on sleep. His research has been published in top journals including Nature Communications , Journal of Sleep Research , and Sleep Medicine , demonstrating interdisciplinary reach. Scientific Awards and Recognition: NHMRC Emerging Leadership Fellow (2023) Helen Bearpark Memorial Scholarship (2022) Emerging Research Leader Award, Flinders University (2021) Multiple early-career awards from Sleep Down Under, Australasian Sleep Association, and Adelaide Sleep Retreat Ranked in the top 5% of international authors in sleep apnea by Expertscape Dr Lechat has secured over $2.5 million in competitive research funding and actively supervises and mentors junior researchers. He serves on the program committee of the American Thoracic Society meetings and contributes to clinical guidelines. He collaborates globally with industry and academic partners to translate research into clinical practice. Laboratories and Research Teams: He co-leads the 'Novel use of digital innovations & technology development' theme at FHMRI: Sleep Health, working closely with Professor Danny Eckert. His team integrates expertise in biomedical engineering, data science, and clinical sleep physiology to advance digital sleep medicine.

• Sleep Disorders
• Obstructive Sleep Apnea
• Digital Health
• +7 more

Dr. Clare Hume is a Senior Lecturer in the School of Public Health at the University of Adelaide, within the Faculty of Health and Medical Sciences. She serves as Program Director for the Honours program in the School and teaches courses in Infant, Child and Adolescent Health, and Communication for Health Sciences. Her research focuses on sustainable environments and children’s health, emphasizing physical activity promotion, reducing sedentary behaviors, and improving nutrition through innovative interventions in family, school, and community settings. She is an Editorial Board member for the American Journal of Health Promotion and Associate Editor for the Health Promotion Journal of Australia . Currently supervising two MPH students and an Honours student, her work bridges environmental sustainability and public health, particularly addressing waste reduction and healthy eating strategies. Key research themes include the impact of built environments on physical activity, interventions targeting screen-time reduction, and policy analysis for health and environmental co-benefits. Dr. Hume’s publications highlight school lunchbox innovations, community garden effects, and the Transform-Us! trial’s impact on children’s cardiometabolic health. Her contributions emphasize translational research to translate evidence into actionable strategies for healthier lifestyles and sustainable practices among children and families.

• Environmental Sustainability
• Children's Health
• Physical Activity Promotion
• +3 more

Christina Gertrude Yap is a Senior Lecturer in Metabolic Medicine at the Jeffrey Cheah School of Medicine and Health Sciences (JCSMHS), Monash University Malaysia. She is actively involved in research, teaching, and academic leadership, with a focus on diabetic nephropathy, metabolic disorders, and medical education. She supervises PhD students and leads multiple research projects in diabetes and obesity. PhD in Biomedical Sciences, Monash University (2012) Graduate Certificate in Higher Education, Monash University (2015) Dr. Yap's research centers on identifying early biomarkers for metabolic syndromes, particularly diabetic nephropathy, with a focus on CYP2E1 and other endogenous molecules. Her work integrates proteomics, metabolomics, and animal models to explore pharmacokinetics, xenobiotic interactions, and translational applications. She also investigates teaching and learning methodologies in medical education. Her recent publications (2021–2025) span diabetes, neuroprotection, obesity, and public health, with a strong emphasis on mechanistic studies and clinical translation. Articles explore hippocampal neuroprotection in diabetic rats, social determinants of obesity, and vaccine mechanisms, reflecting a multidisciplinary approach bridging basic science and public health. Scientific awards include: Best Mention Award, 14th Biological Science Congress (2009) Best Presentation Award, 5th World Congress on Diabetes and Metabolism (2014) First Prize and Best Presentation Award, Monash CSJB Research Week and World Congress on Clinical Trials in Diabetes (2017) Seed Grant Award, Monash University (2024) Dr. Yap has been a PhD supervisor since 2011 and is currently accepting new students. She has secured multiple research grants, including active projects on renal protection in type 2 diabetes and anti-obesity effects of natural compounds. Her leadership roles include coordinating physiology and hematology in the MBBS program and serving on the Student Support Committee. She is a member of the Malaysian Scientific Association and the Malaysian Society of Pharmacology & Physiology. She leads a research team focused on metabolic medicine, utilizing advanced analytical techniques and collaborative networks to advance understanding of diabetes and obesity. Her lab integrates molecular biology, animal models, and clinical data to develop early diagnostic tools and therapeutic strategies.

• Diabetic Nephropathy
• Metabolic Syndrome
• Obesity
• +11 more

Professor Xiaowei Wang is a leading academic at the Baker Heart and Diabetes Institute , where she heads the Molecular Imaging and Nanotherapeutics laboratory and co-leads the Heart Attack Program and Centre for Cardiometabolic mRNA Therapy . She holds adjunct and honorary academic appointments at the University of Melbourne, La Trobe University, Monash University, Swinburne University, and Torrens University. Professor Wang earned her PhD from Monash University and is a Fellow of the Australian Academy of Health Sciences (FAHA), Cardiac Society of Australia and New Zealand (FCSANZ), and European Society of Cardiology (FESC). Her research integrates physics, chemistry, biology, and biotechnology to develop clinical-ready diagnostic and therapeutic solutions for cardiovascular disease. Her work focuses on preclinical molecular imaging using advanced technologies like MRI, PET, and photoacoustic imaging to enable early diagnosis and real-time monitoring of treatments. She pioneers mRNA therapeutics and vaccines delivered via micro- and nano-particles to prevent heart attacks, strokes, and inflammation with minimal side effects. Key trends in her publications highlight targeted drug delivery , thrombosis prevention , Nanotherapeutics , and translational cardiovascular research . Her studies often explore the intersection of molecular imaging , biomedical engineering , and clinical applications . Scientific awards and recognitions: National Heart Foundation Future Leader Fellowship Level 2 Baker Institute Sir Laurence Muir Prize World Molecular Imaging Society Mid Career Award Inaugural Fellow of the Australian Society of Molecular Imaging National Heart Foundation Paul Korner Innovation Award Inaugural Women of Colour in STEM Award AVBS Achievement and Career Development Award 40 Under 40 Most Influential Asian-Australian Award Finalist Professor Wang is also deeply committed to equity and mentorship, chairing the Baker Institute’s Mentoring Committee and serving on leadership teams for the Women in Molecular Imaging Network and the Gender Equity and Diversity Committee. She has received over 27 national and international travel grants, 18 research prizes, and 14 Young Investigator Awards, underscoring her impact in the field.

• Molecular Imaging
• Nanotherapeutics
• Cardiovascular Disease
• +3 more

Dr. Nicola Bondonno is an Adjunct Lecturer and Post-Doctoral Research Fellow at Edith Cowan University's School of Medical and Health Sciences, affiliated with the Nutrition & Health Innovation Research Institute (NHIRI). Her research focuses on plant bioactive compounds (polyphenols, nitrate, vitamin K) and their roles in preventing chronic diseases. She holds a PhD from the University of Western Australia (2018) and has extensive postdoctoral experience. Dr. Bondonno has secured significant funding including NHMRC grants and Raine/Robson Fellowships. Her work spans human intervention studies and prospective cohorts, with publications in high-impact journals like Nature Communications and JAMA Network Open . Awards include the ECU Vice-Chancellor’s Excellence in Research Award (2020) and multiple travel/training grants. Key research areas include dietary nitrate's role in cardiovascular health, flavonoid-rich foods' impact on dementia and diabetes, and vitamin K's effects on vascular and bone health. She collaborates internationally, contributing to large-scale studies like the Danish Diet, Cancer, and Health cohort. Dr. Bondonno leads projects on dietary interventions, such as the VESSEL study on cruciferous vegetables' blood pressure effects, and co-develops databases for nitrate/nitrite content. Her translational work bridges nutrition science with public health, aiming to improve aging and chronic disease outcomes.

• Nutrition
• Cardiovascular Disease Prevention
• Plant Bioactive Compounds
• +7 more

Brett Gordon is an Associate Professor in Exercise Physiology and Head of Department for Rural Clinical Sciences at La Trobe University's Rural Health School in Bendigo, Australia. He is also an Accredited Exercise Physiologist (AEP) with over a decade of academic experience and nearly ten years of clinical practice. PhD from Royal Melbourne Institute of Technology University (2012) MAppSc (Exercise Rehabilitation) from Victoria University BAppSci (Human Movement) from Royal Melbourne Institute of Technology University Professor Gordon's research focuses on the role of exercise in managing chronic disease, particularly examining how exercise can be optimally assessed and prescribed for people with cardiometabolic health conditions. His work utilizes continuous glucose monitoring systems, accelerometers, and GPS monitors to study both healthy individuals and those with health conditions. Early in his career, he investigated exercise benefits for children with chronic fatigue syndrome before shifting focus to cardiometabolic health. Analysis of his recent publications reveals a strong emphasis on practical applications of exercise physiology in real-world settings, particularly in rural communities. His research spans walking football programs for older adults, optimal exercise dosing for cardiac rehabilitation, e-bike health benefits, military transition health issues, and telehealth applications for cardiac rehabilitation. A consistent theme across his work is addressing health disparities in rural populations. Member of Exercise and Sports Science Australia (ESSA), Research Committee Associate Editor for Frontiers in Sports and Active Living Member of Scientific Reports Editorial Board Member of American Association of Cardiovascular and Pulmonary Rehabilitation Professor Gordon has successfully supervised numerous students to completion, including 3 honours students (all H1), 1 master's student, and 5 doctoral students. He currently supervises 5 PhD candidates and 2 Master by Research candidates. His funded research includes projects on walking football for older adults and exercise demands in adolescent athletes. He maintains a broad collaborative network including institutions such as Auckland, Swinburne, Sheffield Hallam, Murdoch, RMIT, and Deakin universities, as well as Bendigo Health, The Austin Hospital, and the Baker IDI Heart and Diabetes Institute. His current research projects focus on prediabetes, diabetes, heart disease, hospital care, military transition, and resistance training, demonstrating his commitment to translating exercise science into practical health interventions for diverse populations.

• Exercise Physiology
• Diabetes
• Cardiovascular Disease
• +4 more

Dr. Sara Ballouz is a Senior Lecturer at the University of New South Wales (UNSW) , affiliated with the Garvan Institute of Medical Research and the Garvan-Weizmann Centre for Cellular Genomics . Her research integrates computational and experimental approaches to understand the genetic architecture of disease , with a focus on X-linked disorders , sex differences in disease , and personalized medicine . 2013 - PhD, Victor Chang Cardiac Research Institute and UNSW 2008 - BE Bioinformatics (First Class Honours), UNSW 2008 - BSc Genetics, UNSW Her work addresses challenges in analyzing multi-omics data (genomes, transcriptomes, epigenomes, proteomes) to develop robust tools for personalized medicine. Key contributions include improving RNA-seq accuracy through pan-human consensus genomes and creating computational methods like AuPairWise and CoCoCoNet for co-expression analysis. She explores developmental stochasticity and its transcriptional legacy, alongside cross-tissue X-chromosome inactivation patterns. Recent publications emphasize single-cell transcriptomics applications in autoimmune diseases (e.g., X-linked chronic granulomatous disease ), long COVID immune dysregulation , and cardiometabolic disease treatment. Her group at Garvan-Weizmann Centre leverages computational genomics and meta-analysis to address reproducibility in biomedical research. Dr. Ballouz supervises students including Lachlan Gray , who investigates X chromosome roles in female autoimmune disease . She collaborates with institutions like Cold Spring Harbor Laboratory and Victor Chang Cardiac Research Institute . Email: s.ballouz@unsw.edu.au

• Transcriptomics (single-cell and bulk)
• Co-expression
• X-linked disorders
• +3 more

Dr. Tina Cao is a Lecturer in Dietetics and Human Nutrition within the School of Food, Nutrition and Dietetics at La Trobe University. She holds an Honorary position at Baker Heart and Diabetes Institute and collaborates with researchers from Monash University and Northern Health. Her academic journey includes previous Research Fellow positions at Baker IDI Heart and Diabetes Institute and the University of Melbourne. Dr. Cao's educational background spans medical training (MBBS from Jiangsu University, China), public health (MMedSc from Karolinska Institute, Sweden), and epidemiology (PhD from University of Adelaide, Australia). Her diverse academic preparation has positioned her at the intersection of clinical medicine, public health, and nutritional science. Her research interests focus on cardiometabolic disease prevention through nutrition and lifestyle interventions at the population level. Dr. Cao investigates the complex relationships between dietary patterns, physical activity, sedentary behavior, and cardiometabolic outcomes, with particular attention to disadvantaged and culturally diverse populations in Australia. Her work bridges nutritional epidemiology with implementation science, developing evidence-based interventions that address health inequities. Dr. Cao frequently utilizes large-scale datasets like the China Health and Nutrition Survey and the AusDiab study in her research. Dr. Cao's publication record demonstrates consistent productivity with nearly 40 peer-reviewed journal articles and a national report, accumulating over 830 citations since 2019. Her recent work shows increasing focus on health literacy integration into chronic care models, particularly for culturally and linguistically diverse populations with type 2 diabetes. She has made significant contributions to understanding unmet needs in diabetes self-management and the role of digital health solutions during the pandemic. Her scientific recognition includes: Membership in the Australian Diabetes Society (since 2024) Membership on the La Trobe Academic Board (since 2024) Membership in The Nutrition Society of Australia (since 2016) As an educator, Dr. Cao supervises honors and master's students and teaches research-focused subjects including HEA 201 (Integrating Evidence into Practice), DTN 304 (Nutritional Epidemiology and Research Skills), and DTN 306/312 (Nutrition Research projects). She actively collaborates with Professor Brian Oldenburg at Baker Heart and Diabetes Institute and Associate Professor Rebecca Jessup at Northern Health, focusing on culturally diverse populations' health needs. Dr. Cao is committed to translating research findings into practical applications that address health inequities, particularly in the Australian context where cultural diversity presents unique challenges for chronic disease management. Dr. Cao maintains an active research agenda with multiple ongoing projects examining cardiometabolic health in diverse populations, digital health interventions, and implementation strategies for chronic disease management. Her work bridges academic research with practical healthcare solutions, demonstrating her commitment to improving population health outcomes through evidence-based practice.

• Public Health Research
• Cardiometabolic Disease Prevention
• Nutritional Epidemiology
• +7 more